Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-09-02
1994-04-05
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514326, 514336, 514422, 514444, 514445, 544146, 546212, 546213, 546268, 546284, 548527, 549 59, 549 60, 549 64, 549 65, A61K 3138, C07D33332
Patent
active
053004990
ABSTRACT:
The present invention provides novel carbonic anhyrase inhibitors represented by the structural formula: ##STR1## wherein R.sub.1 and R.sub.2 are, for example, independently (a) hydrogen; or
REFERENCES:
patent: 3888879 (1975-06-01), Edwards
patent: 4386098 (1983-05-01), Woltersdorf, Jr. et al.
patent: 4416890 (1983-11-01), Woltersdorf, Jr.
patent: 4426388 (1984-01-01), Woltersdorf, Jr.
patent: 4477466 (1984-10-01), Shephard
patent: 4486444 (1984-12-01), Shepard
patent: 4542152 (1985-09-01), Shephard
patent: 4544667 (1985-10-01), Shephard et al.
patent: 4585787 (1986-04-01), Shephard
patent: 4665090 (1987-05-01), Grahm
patent: 4847289 (1989-07-01), Baldwin
patent: 4914111 (1990-04-01), Hartman et al.
patent: 4929637 (1990-05-01), Baldwin et al.
Allergan Inc.
Baran Robert J.
Hoch James M.
Raymond Richard L.
Voet Martin A.
LandOfFree
5-substituted 3-thiophene sulfonamides as antiglaucoma agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-substituted 3-thiophene sulfonamides as antiglaucoma agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-substituted 3-thiophene sulfonamides as antiglaucoma agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-511135